|
Model Number SC-035-135 |
Device Problems
Fracture (1260); Difficult to Remove (1528); Detachment of Device or Device Component (2907)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 08/25/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Physician intended to use a trailblazer support catheter during treatment of a calcified cto (chronic total occlusion-100%) in the patient¿s proximal left common iliac artery and superficial femoral artery.Severe vessel calcification and tortuosity are reported.Ifu was followed.It is reported the catheter broke while removing the device over the common iliac bifurcation.The catheter fragments remained stuck on the guidewire.A 10mm gooseneck snare was used to retrieve the broken catheter.When the trailblazer was removed from the patient, a long sheath was used to crossover bifurcation and treat the intended vessel.No further injury reported.
|
|
Manufacturer Narrative
|
Additional information: all components of the device were removed from the patient.There was no vessel damage noted.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Product analysis: the trailblazer was returned to medtronic investigation lab for evaluation.The device inside a red biohazard bag with portion of the trailblazer pouch.No ancillary devices were included.The trailblazer was fractured apart into two segments.Dried blood was observed within the catheter lumen.The distal segment showed all three marker bands were present and accounted for.The distal segment was approximately 14cm long.The proximal end of the segment showed a radial ductile fracture.The proximal end of the shaft at the area of the fracture showed buckling of the catheter outer.The proximal segment showed the strain relief was consistent with the product labeling.(indicated 0.035" x 135cm).The total working length of the proximal segment was approximately 122cm.The distal end of this segment showed a radial ductile fracture face.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|